Project Grant K08CA304376
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) will fund a study to evaluate the implementation and impact of oncology financial navigation services as part of routine cancer care delivery at the University of Alabama at Birmingham (UAB). The $192,489 grant will support a 5-year research project focused on understanding how to effectively implement oncology financial navigation programs, which help cancer patients prepare for out-of-pocket...
- This $126,738 Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) supports the implementation of a community-based cancer prevention intervention targeting a marginalized population experiencing food insecurity. The key objectives are to: (1) identify barriers and facilitators to implementing a cancer prevention intervention in a food distribution setting; (2) develop a tailored community-based cancer prevention intervention to promote breast...
- This federal Project Grant award for $4,236,812 was provided by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Children's Hospital Los Angeles. The grant supports a study to evaluate a patient navigation intervention for improving transition to adult survivorship care among disadvantaged young adult survivors of childhood cancer. The project aims to address the significant challenges and disparities faced by this population, including high rates of...
- The National Cancer Institute (NCI), under the federal Cancer Research Manpower program (CFDA 93.398), awarded a $222,749 project grant to Rutgers, The State University of New Jersey. The funding will be used to adapt, refine, and pilot test a single-session digital intervention (SSI) aimed at reducing psychological distress in adolescent siblings of children with cancer. The project, which runs from August 1, 2025 to July 31, 2030, will involve adapting an existing SSI to meet the specific...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $191,490 to the University of Kansas Medical Center Research Institute, Inc. to implement and evaluate an adaptive clinical workflow for screening and referring cancer patients with employment concerns to existing support resources. The key objectives are to conduct a patient-level needs assessment, evaluate implementation determinants at the clinic level, and pilot test the screening...
- The National Cancer Institute awarded a $185,693 Project Grant titled "A Digital Health Parent Coaching Intervention to Improve Neurodevelopmental Outcomes for Young Childhood Cancer Survivors in Underserved Communities" under the Cancer Research Manpower (CFDA 93.398) federal grant program. The grant recipient, the Research Institute at Nationwide Children's Hospital, will conduct research to develop a digital health intervention to support parents of young childhood cancer...
- The National Cancer Institute (NCI), a component of the Department of Health and Human Services National Institutes of Health, awarded a $319,505 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the Regents of the University of Michigan. The grant, awarded on Aug 1, 2025, will fund a 5-year project to build nationwide investigator capacity in methods for adapting and personalizing cancer control interventions. The project aims to deliver comprehensive...
- The federal Project Grant award of $637,596 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) is for a research project titled "Interventions to Decrease Cancer Information Avoidance". The goal is to develop and test a video-based intervention designed to reduce defensive avoidance of colorectal cancer information and increase engagement, in order to improve screening rates among those who typically avoid such information (about 20% of the...
- This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
- The University of North Carolina at Chapel Hill was awarded a $197,747 Project Grant by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) to pilot and refine the "Improving Affordability in Cancer Care through Economic Screening and Support (I-ACCESS)" program. The objective is to develop a screening assessment and referral process to proactively identify cancer-related financial hardship in patients and connect them with education, counseling, and...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $249,647 to The University of Texas Southwestern Medical Center to develop and pilot test a novel "Benefits Navigator" intervention. The intervention aims to address unmet social needs, such as housing, food, utility, and transportation insecurity, among children with newly diagnosed cancer. The key products and services to be delivered under this award include: 1) Refinement of the intervention prototype based on parent and community advisory board input to optimize intervention components and delivery, and 2) Pilot testing of the refined intervention to assess feasibility, acceptability, and preliminary efficacy in improving benefits receipt, reducing food insecurity, and decreasing parental distress. This award will also leverage a national dataset to identify patterns and predictors of Supplemental Nutrition Assistance Program (SNAP) non-participation among eligible families of children with acute lymphoblastic leukemia as an exemplar means-tested benefit. The results will inform the approach for a subsequent larger-scale efficacy evaluation of the Benefits Navigator intervention.